Effects of ramipril on parameters of oxidative stress and advanced glycation end products in non-diabetic nephropathy.

被引：0
|
作者：
Sebekova, K
Gazdikova, K
Blazicek, P
Schinzel, R
Heidland, A
Spustova, V
Dzurik, R
机构：
[1] IPCM, Bratislava, Slovakia
[2] Mil Hosp, Bratislava, Slovakia
[3] Univ Wurzburg, Wurzburg, Germany
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：266A / 266A
页数：1
相关论文
共 50 条
  • [21] Advanced glycation end products are associated with impaired vascular reactivity in non-diabetic subjects
    Matsuoka, H
    Murase, E
    Sugano, R
    CIRCULATION, 2001, 104 (17) : 370 - 370
  • [22] The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice
    Hansen, Laura M.
    Gupta, Divya
    Joseph, Giji
    Weiss, Daiana
    Taylor, W. Robert
    LABORATORY INVESTIGATION, 2017, 97 (01) : 34 - 42
  • [23] CUTANEOUS ADVANCED GLYCATION END PRODUCTS (AGEs) - A PREDICTOR OF DIABETIC NEPHROPATHY?
    Dumann, Konstantin
    Hoerrmann, Britta
    Lammert, Alexander
    Gorski, Mathias
    Kraemer, Bernhard
    Heid, Iris
    Boeger, Carsten
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 168 - 168
  • [24] Role of advanced glycation end products and insulin resistance in diabetic nephropathy
    Parwani, Kirti
    Mandal, Palash
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 129 (01) : 95 - 107
  • [25] Advanced Glycation End Products May Predict Progression of Diabetic Nephropathy
    Beisswenger, Paul J.
    Howell, Scott
    Mauer, Michael
    Russell, Greg
    Miller, Mike
    Rich, Stephen
    DIABETES, 2012, 61 : A79 - A80
  • [26] Receptor for advanced glycation end products is a promising target of diabetic nephropathy
    Yamamoto, Y
    Doi, T
    Kato, I
    Shinohara, H
    Sakurai, S
    Yonekura, H
    Watanabe, T
    Myint, KM
    Harashima, A
    Takeuchi, M
    Takasawa, S
    Okamoto, H
    Hashimoto, N
    Asano, M
    Yamamoto, H
    MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 : 562 - 566
  • [27] Roles of advanced glycation end-products in the progression of diabetic nephropathy
    Makino, H
    Shikata, K
    Kushiro, M
    Hironaka, K
    Yamasaki, Y
    Sugimoto, H
    Ota, Z
    Araki, N
    Horiuchi, S
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 76 - 80
  • [28] A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy
    Khanam, Afreen
    Ahmad, Saheem
    Husain, Arbab
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2023, 24 (01) : 2 - 6
  • [29] Effects of Ramipril, Telmisartan and Amlodipine Medications on the Development of Diabetic Nephropathy and Advanced Glycation End Products in Patients With Type 2 Diabetes Mellitus and Hypertension
    Yalcin, Yavuz
    Yalcin, Funda
    Kocak, Gulay
    Azak, Alper
    Mete, Turkan
    Guler, Serdar
    Duranay, Murat
    DIABETES, 2013, 62 : A610 - A610
  • [30] The glomerular localization of CML and non-CML advanced glycation end products in diabetic nephropathy
    Yanagisawa, K
    Ueno, H
    Takeuchi, M
    Iriyama, R
    Makita, Z
    Koike, T
    DIABETES, 1998, 47 : A372 - A372
12345